| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Angela Nelms last filed a Form 4 in January 2024, as Chief Operating Officer at RNXT. Angela Nelms's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 1,100 shares of RNXT. Net of sales, the RNXT filings show accumulation of 1,100 shares.
Angela Nelms has 4 Form 4 filings on record from September 2022 to January 2024, all as Chief Operating Officer at RenovoRx (RNXT), 2022–2024.
The 6 reported transactions were 4 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 1 purchase worth about $1K and no sales.
The only open-market purchase was 1,100 shares of RNXT at an average $1.05 on October 3, 2023, about $1K. Twelve months later RNXT was down 4%.
Shares as reported in the last Form 4 for each company; the most recent is from January 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | RNXT Renovorx, Inc. | Chief Operating Officer | Buy | 1,100 | $1.05 | $1,150.97 | New | +88.6% | -4.3% |